Damian Garde and Allison DeAngelis

BioTech

Who discovered GLP-1? Plus: BrainStorm at the FDA and biotech’s slump

When is negative data positive enough? Who gets credit for scientific breakthroughs? And wasn’t biotech supposed to bounce back? We cover all that and more

Damian Garde and Allison DeAngelis September 28, 2023

BioTech

A thorny ALS debate at the FDA, and the promise of artificial wombs

Can the FDA be too flexible? How do you test a mechanical womb? And who decides what’s good enough for patients in need? We cover

Damian Garde and Allison DeAngelis September 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Damian Garde and Allison DeAngelis

Who discovered GLP-1? Plus: BrainStorm at the FDA and biotech’s slump

A thorny ALS debate at the FDA, and the promise of artificial wombs

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe